Research and Training in Complementary and Integrative Health
Active
- Assistance listing
- 93.213
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- 3,796 $2,993,837,270 in federal obligations
Program facts
- Also known as
- National Center for Complementary and Integrative Health
- Assistance types
-
- Project Grant
- Cooperative Agreement
- Block Grant
- Treasury account
-
- 75-0896-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The National Center for Complementary and Integrative Health (NCCIH) within the National Institutes of Health funds research and training in complementary and integrative health approaches, with CFDA 93.213, and most recently awarded funding on February 28, 2027. The program supports scientific investigation into the fundamental science, safety, and usefulness of complementary and integrative treatments and practices, favoring rigorous mechanistic understanding alongside clinical application.
Awarded grants target diverse conditions through mind-body and bioactive interventions: dietary modulation of the gut microbiota during pregnancy and infant health, role strain and self-compassion in ALS caregivers, prenatal mindfulness for stress and birth outcomes, family resilience in breast cancer survivors, bidirectional brain-computer interfaces combining EEG and ultrasound neuromodulation, pain catastrophizing neurobiology in burn survivors, mobile app-based mindfulness for spinal cord injury pain, singing for cardiovascular health in older adults, and multimodal interventions for chronic pain in diverse populations. Recent awards also span microbiome therapeutics, natural product drug discovery for analgesia, cannabis coaching for chronic low back pain, acupuncture in emergency departments, and music-based interventions for dementia and chronic pain.
The program is predominantly Project Grants (91 percent of 3,465 awards), with smaller shares of Block Grants (6 percent) and Cooperative Agreements (3 percent). The National Center for Complementary and Integrative Health leads funding with $1.79 billion across 942 awards, followed by the broader NIH with $959.7 million across 2,733 awards. Combined federal dollars obligated total $2.99 billion across 3,796 awards since 1992. Annual award volume averaged 61–83 grants per year from 2023–2026, dropping to 3 awards in early 2027. Recent project awards range from $46 thousand to $1.67 million, with several multi-year efficacy trials, feasibility studies, and proof-of-concept investigations in the $600 thousand to $800 thousand range.
Grant opportunities currently open include HEAL Initiative funding for translating addiction and chronic pain research into practice (RFA-DA-27-016, due Feb 9, 2029), NIH pragmatic trials in health care systems (PAR-28-010), small business transition grants for new entrepreneurs (PAR-27-039 and PAR-27-040), and mind and body interventions for whole person health via emotional well-being mechanisms (PAR-25-449, due Jun 7, 2028). Applicants include universities, research institutions, nonprofits, and small businesses; foreign organizations are ineligible for most NCCIH mechanisms.
Objective and description
- Objective
NCCIH is the lead Federal agency for scientific research on the fundamental science, usefulness, and safety of complementary and integrative treatments and practices. NCCIH seeks to build knowledge across disciplines, focusing on the whole person, an
- Description
The National Center for Complementary and Integrative Health (NCCIH) provides funding for research into complementary and integrative health approaches. Eligible entities (including, but not limited to: research and academic institutions, private companies) may submit research grant applications using the Grants.gov website. All applications undergo a rigorous, 2-stage, peer-review system, and funding decisions are made based on the review of applications that are most meritorious and responsive to the mission of NCCIH.
Eligibility
- Applicant eligibility
Universities, colleges, hospitals, laboratories, and other public or private nonprofit domestic institutions, including State and local units of government, and individuals are eligible to make application for grant support of research by a named principal investigator or a research career development candidate. For-profit organizations are also eligible, with the exception of NRSA. Individual NRSA awardees must be nominated and sponsored by a public or nonprofit private institution having staff and facilities appropriate to the proposed research training program. All NRSA awardees must be citizens or have been admitted to the United States for permanent residence. To be eligible, predoctoral candidates must have completed the baccalaureate degree, and postdoctoral awardees must have a professional or scientific degree (e.g., M.D., Ph.D., D.D.S., D.O., N.D., D.C., D.V.M., Sc.D., D.Eng., or equivalent domestic or foreign degree). SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is being proposed and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. or its possessions. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which researches proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
- Beneficiary eligibility
Any nonprofit or for-profit organization, company, or institution engaged in biomedical research.
- Uses of assistance
Research Grants provide funds for salaries, equipment, supplies, travel, and other expenses associated with scientific investigation relevant to program objectives. Individual National Research Service Awards (NRSAs) are made to individuals for research training in specified biomedical shortage areas. In addition, grants may be made to institutions to enable them to make NRSAs to individuals selected by them. Each individual who receives a NRSA is obligated upon termination of the award to comply with certain service and payback provisions. Small Business Innovation Research (SBIR) Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants are for the continuation of the research initiated in Phase I that are likely to result in commercial products or processes. Only Phase I awardees are eligible to receive Phase II support. Small Business Technology Transfer (STTR) Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential on Phase II application.
- Length and time phasing of assistance
Research Project Grants (including most Cooperative Agreements): Awards are usually made for a 12-month period with recommendation of up to 4 years of additional support. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years. See the following for information on how assistance is awarded/released: The Notice of Award (NoA) is the legal document issued to notify the grantee that an award has been made and that funds may be requested from the designated HHS payment system or office. A NoA is issued for the initial budget period. If subsequent budget periods are also approved, the NoA will include a reference to those budgetary commitments. Funding for subsequent budget periods are generally provided in annual increments following the annual assessment of progress. This funding is also contingent on the availability of funds. The NoA includes all applicable terms of award either by reference or specific statements. It provides contact information for the assigned program officer and grants management specialist. The grantee accepts an NIH award and its associated terms and conditions by drawing or requesting funds from the Payment Management System, or upon the endorsement of a check from the US Treasury for foreign awardees.
How to apply
- Criteria for selecting proposals
The major elements in evaluating proposals include assessments of: (1) the scientific merit innovation and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; (6) the relevance and importance to the announced program objectives and when applicable,and (7) the adequacy of assurances detailing the proposed means for safeguarding human or animal subjects. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; and (8) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.
- Award procedure
Award Procedure: All accepted applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score ranging from the best (10) to worst (90) compete for available funds based on scientific merit, program relevance, and program balance and are made annually. Initial award provides funds for the first budget period (usually 12 months) and Notice of Grant Award (Form PHS 1533) indicates support recommended for remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
- Time to approval or disapproval
Overall from 180 to 300 days. Research Grants and Cooperative Agreements: approximately 6-10 months; National Service Research Awards: 6-9 months; SBIR/STTR awards 6 - 7 months.
- Renewals
Research grants: renewals by competitive application and review. Extension by request and administrative action. National Research Service Awards: individual awards may be made for 1, 2, or 3 years. No individual may receive NIH fellowship support at the postdoctoral level for more than 3 years.
- Appeals
An applicant institution (including the Authorized Organization Representative and the Program Director/Principal Investigator (PD/PI)) may question the substantive or procedural aspects of the review of their application by submitting an appeal. An appeal is a written communication from the applicant that meets the following three criteria: 1) is received after issuance of the summary statement and up to 30 calendar days after the second level of peer review, 2) describes a flaw or perceived flaw in the review process for a particular application, 3) is based on one or more of four allowable issues (described below). The four allowable issues are: (1) evidence of bias on the part of one or more peer reviewers; (2) conflict of interest, as specified in regulation at 42 CFR 52h.5."Scientific Peer Review of Research Grant Applications and Research and Development Contract Projects", on the part of one or more peer reviewers; (3) lack of appropriate expertise within the scientific review group (which performed the peer review); and (4) factual error(s) made by one or more reviewers that could have substantially altered the outcome of review. A description of the NIH Peer Review Policy and Procedures is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.
Grant opportunities
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Grant awards
Latest 10 of 3,796 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | The General Hospital Corporation | $125,864,069 | 4% |
| 2 | The Regents Of The University Of California. San Francisco | $74,704,447 | 2% |
| 3 | Duke University | $72,119,793 | 2% |
| 4 | Regents Of The University Of Minnesota | $60,346,431 | 2% |
| 5 | University Of California, San Diego | $51,372,554 | 2% |
| 6 | University Of California, LOS Angeles | $50,705,171 | 2% |
| 7 | University Of Washington | $49,890,301 | 2% |
| 8 | Yale Univ | $48,514,856 | 2% |
| 9 | University Of Illinois | $43,423,156 | 1% |
| 10 | The Leland Stanford Junior University | $39,812,962 | 1% |
10 of 468 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $82,325,112 |
| FY2025 | $164,911,797 |
| FY2024 | $222,592,037 |
| FY2023 | $261,642,711 |
| FY2022 | $232,962,377 |
| FY2021 | $247,889,527 |
| FY2020 | $148,733,639 |
| FY2019 | $149,394,195 |
| FY2018 | $126,574,085 |
| FY2017 | $108,087,945 |
| FY2016 | $110,826,456 |
| FY2015 | $100,048,562 |
| FY2014 | $103,093,815 |
| FY2013 | $99,028,295 |
| FY2012 | $109,414,344 |
| FY2011 | $99,199,901 |
| FY2010 | $98,869,742 |
| FY2009 | $101,833,630 |
| FY2008 | $47,761,293 |
| FY2007 | $70,335,922 |
| FY2006 | $92,014,286 |
| FY2005 | $92,546,548 |
| FY2004 | $88,855,215 |
| FY2003 | $89,383,965 |
| FY2002 | $79,565,238 |
| FY2001 | $34,758,507 |
Show all 26
Quick answers
What is Assistance Listing 93.213?
Assistance Listing 93.213 is Research and Training in Complementary and Integrative Health, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Research and Training in Complementary and Integrative Health?
Its CFDA number is 93.213: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.213 awarded?
3,796 grant awards under 93.213 have obligated $2,993,837,270 in federal funds to 468 recipients.
Who receives the most funding from 93.213?
The recipients obligated the most under Research and Training in Complementary and Integrative Health are The General Hospital Corporation ($125,864,069), The Regents Of The University Of California. San Francisco ($74,704,447) and Duke University ($72,119,793).
How much did 93.213 obligate in fiscal year 2025?
Grants under 93.213 obligated $164,911,797 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.213?
38 of the latest 50 opportunities under 93.213 are open or forecasted. The latest, HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional), was posted on June 4, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program